Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid

NCT04315415 is registered in ClinicalTrials.gov with Sofregen Medical, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04315415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid
Lead sponsor
Sofregen Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2020
Completion date
April 18, 2022
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vocal cord atrophy, vocal cord paralysis, vocal fold palsy